Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2

Renal cell carcinoma (RCC) is one of the most common malignant tumors affecting the urogenital system, accounting for 90% of renal malignancies. Traditional chemotherapy options are often the front-line choice of regimen in the treatment of patients with RCC, but responses may be modest or limited d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Pharm Sin B
Main Authors: Chen, Lu, Chen, Le, Qin, Zhiyuan, Lei, Jinxiu, Ye, Sheng, Zeng, Kui, Wang, Hua, Ying, Meidan, Gao, Jianqing, Zeng, Su, Yu, Lushan
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Original article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804444/
https://ncbi.nlm.nih.gov/pubmed/31649850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados